版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)
文檔簡(jiǎn)介
1、石河子大學(xué)碩士學(xué)位論文HNPCC家系篩查及HNPCC家系中hMLH1、hMSH2蛋白表達(dá)分析姓名:丁元升申請(qǐng)學(xué)位級(jí)別:碩士專業(yè):外科學(xué)指導(dǎo)教師:張劍權(quán);黃桂林2011-06II Abstract Objective: To build up the complete date for this hereditary nonpolyposis colorectal cancer family member, and to draw a p
2、arentage map of it. Draw up scientific and individuated follow-up visit schedule for the members in this parentage according to the result of expression of hMLH1、hMSH2. And to supply a advanced screen for the research gr
3、oup which to study the germline mutations of human mismatch repair gene hMLH1 and hMSH2 in this parentage. Method: 1. Screening of hereditary nonpolyposis colorectal cancer: Set up follow-up records for all the members
4、in this family and follow-up visit should be carried out by means of telephone, letter and face to face interview. Consummate clinical data, then draw the family map which the proband was made the core and do pedigree an
5、alysis of it. 2. Detection of expression of hMLH1 or hMSH2 protein: The tumor tissues of HNPCC group and normal intestine mucosa of the members of this family were immunohistochemically examined for hMLH1 and hMSH2, the
6、n we analyzed the relationship and correlation of negative expression in HNPCC group with clinicopathologic findings. Result: 1. The family have 105 members, and 76 members have direct relative with proband, and 8 member
7、s died because of hereditary nonpolyposis colorectal cancer, and 7 member died because other disease. In this parentage, 17 members have hereditary nonpolyposis colorectal cancer, 15 cases are colorectal cancer, and 4 me
8、mbers onset age <50,and 10 occurrence in the right half colon, 5 occurrence are in the left half colon. In pathology tape, tubular adenocarcinoma is 3 cases, mucinous adenocarcinoma is 7 cases, and mixed carcinoma is 5 c
9、ases. And well-differentiated is 3 cases, moderately differentiated is 4 cases, poorly differentiated is 8 cases. In addition, extra colonic tumor in this parentage, gastric cancer is 1 case, endometrial cancer is 4 case
10、s. 2. The negative expression of hMLH1 in the HNPCC group and healthy member group is 5 cases and 4 cases. The negative expression of hMSH2 in the HNPCC group and healthy member group is 4 cases and 2 cases. We had not f
11、ound hMLH1 and hMSH2 protein expressed at the same time in the same case. Conclusion: 1.This family is a fulfilled criteria of Amsterdam Ⅱ,and is a classical HNPCC parentage. 2.In the HNPCC group, the negative expression
12、 of hMLH1 and hMSH2 protein have significant difference in the tumor position and the degree of pathological differentiation, and highly related with them. But have no significant difference in the sex, the onset age and
13、 the class of Dukes. 3. Detection of expression of hMLH1 or/and hMSH2 protein would help to make pefect plan of the follow-up for this family. Key words: Colorectal cancer; hereditary nonpolyposis colorectal cancer; Mis
溫馨提示
- 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
- 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
- 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
- 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
- 5. 眾賞文庫僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
- 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
- 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。
最新文檔
- hMLH1和hMSH2基因蛋白在散發(fā)性大腸癌中的表達(dá)及意義.pdf
- 胃癌中hMLH1、hMSH2基因表達(dá)及其與HP感染的關(guān)系.pdf
- hMLH1、hMSH2蛋白在子宮內(nèi)膜異位癥組織中的表達(dá)及意義.pdf
- 涎腺多形性腺瘤hMSH2、hMLH1蛋白的表達(dá)和意義.pdf
- 大腸癌發(fā)生過程中錯(cuò)配修復(fù)蛋白hMSH2、hMLH1表達(dá)的意義.pdf
- 早期胃癌中hMLH1和hMSH2及其甲基化的表達(dá)與意義.pdf
- 錯(cuò)配修復(fù)基因hMLH1、hMSH2在鼻咽癌中的蛋白表達(dá)及臨床意義.pdf
- hMLH1、hMSH2和PCNA在甲狀腺乳頭狀癌中的表達(dá)及臨床意義.pdf
- Cr(Ⅵ)致A549細(xì)胞毒性中hMLH1 hMSH2 P53的表達(dá)變化.pdf
- 錯(cuò)配修復(fù)基因hMLH1和hMSH2在胃癌組織中的表達(dá)及其意義.pdf
- Musashi-2、CD133與錯(cuò)配修復(fù)基因hMLH1、hMSH2蛋白在結(jié)腸腺癌中的表達(dá)及意義.pdf
- 人類錯(cuò)配修復(fù)基因hmlh1和hmsh2錯(cuò)義突變真核表達(dá)載體的構(gòu)建及表達(dá)
- 錯(cuò)配修復(fù)基因hMSH2、hMLH1基因表達(dá)與胃癌發(fā)生關(guān)系的研究.pdf
- 錯(cuò)配修復(fù)基因hMLH1、hMSH2與p53、Rb蛋白在尖銳濕疣中的表達(dá).pdf
- 鮑溫病HPV分型檢測(cè)和hMLH1、hMSH2、p16、p53蛋白的表達(dá).pdf
- DNA修復(fù)基因hMLH1、hMSH2及XRCC3在子宮內(nèi)膜腺癌組織中的表達(dá)及意義.pdf
- 藏、回、漢族胃癌患者h(yuǎn)MLH1和hMSH2基因的差異性表達(dá)及意義.pdf
- 錯(cuò)配修復(fù)基因hMLH1、hMSH2、PMS2在散發(fā)性結(jié)直腸癌中的表達(dá).pdf
- 錯(cuò)配修復(fù)基因hMLH1和hMSH2在下咽癌及切緣中的表達(dá)及臨床意義.pdf
- Lynch綜合征相關(guān)性子宮內(nèi)膜癌中hMLH1、hMSH2、hMSH6及hPMS2的表達(dá)及意義.pdf
評(píng)論
0/150
提交評(píng)論